HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$4.97
Day range
$4.74 - $4.98
Year range
$3.86 - $20.60
Market cap
44.87M USD
Avg Volume
40.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 12.70M | 145.35% |
Operating expense | 8.85M | -46.42% |
Net income | 204.00K | 101.19% |
Net profit margin | 1.61 | 100.48% |
Earnings per share | 0.25 | 106.76% |
EBITDA | 1.64M | 110.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.40M | -51.78% |
Total assets | 39.11M | -24.81% |
Total liabilities | 56.59M | -13.35% |
Total equity | -17.48M | — |
Shares outstanding | 9.45M | — |
Price to book | -2.63 | — |
Return on assets | 9.29% | — |
Return on capital | 16.68% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 204.00K | 101.19% |
Cash from operations | -10.04M | 38.60% |
Cash from investing | — | — |
Cash from financing | -4.16M | -549.22% |
Net change in cash | -14.20M | 16.52% |
Free cash flow | -10.83M | -0.86% |
About
Founded
2013
Headquarters
Website
Employees
71
